For Physicians
Strengthening Vein Grafts for Long-Term Success
DurVena’s Photochemical Tissue Passivation (PTP) technology is designed to enhance the structural integrity of saphenous vein grafts (SVGs), significantly improving their durability in Coronary Artery Bypass Graft (CABG) procedures.
Reducing Graft Failure & Cardiovascular Events
Combat High Failure Rates
Without structural reinforcement, 15-25% of vein grafts fail within the first year, and nearly 50% within five years, leading to increased myocardial infarctions (MI), revascularizations, and mortality rates.
Enhances Long-Term Patency
PTP strengthens vein grafts, reducing expansion and improving durability to lower the risk of failure and major cardiovascular events (MACE).
Simple Addition to Standard Workflow
PTP applies in minutes with no extra incisions or graft modifications, seamlessly fitting into existing surgical procedures.
How to Implement PTP in Your Practice
Integrating PTP is simple, with a quick, user-friendly application that seamlessly fits into existing vein graft preparation. The system ensures consistent, reproducible results with minimal disruption to surgical workflows. Training and support are available for rapid onboarding, allowing teams to experience the benefits firsthand. This product is not yet commercially available in the US. Please check back for updates on our upcoming clinical trial!